Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis

INTRODUCTION: The once-daily long-acting muscarinic antagonist (LAMA) tiotropium and once-daily long-acting β(2)-agonist (LABA) olodaterol have been studied as a once-daily fixed-dose combination (FDC) in patients with chronic obstructive pulmonary disease (COPD). Two large, 52-week, double-blind, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferguson, Gary T., Fležar, Matjaž, Korn, Stephanie, Korducki, Lawrence, Grönke, Lars, Abrahams, Roger, Buhl, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486785/
https://www.ncbi.nlm.nih.gov/pubmed/26112656
http://dx.doi.org/10.1007/s12325-015-0218-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486785/
https://www.ncbi.nlm.nih.gov/pubmed/26112656
http://dx.doi.org/10.1007/s12325-015-0218-0

Ejemplares similares